SWOG Cancer Research Network
SWOG Cancer Research Network runs publicly funded clinical trials that have saved 3 million+ years of life. Founded by the National Cancer Institute in 1956. Member NCTN & NCORP. Online at swog.org. @SupportingSWOG.bsky.social partner.
- Lung-MAP Advocacy Webinar Trial updates + wisdom of #lungcancer advocacy org leaders: how to advance treatments & better meet patient needs. #lcsm Bryan Faller, MD @lungcancerlcfa.bsky.social @lungevity.bsky.social @waroncancer.bsky.social @metcrusaders.bsky.social ! www.youtube.com/watch?v=sFQh...
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- Study @swog.org S2408 is a randomized ph 3 surgical trial testing lanreotide to prevent #pancreatic fistula following distal #pancreatectomy. Also compares measures of quality of life across arms. #pancsm SWOG.org/clinical-trials/S2408 PI: Jonathan G. Sham, MD @fredhutch.bsky.social
- TOMORROW: Lung-MAP Advocacy Webinar Wed., May 14, 1-2 pm ET 1-hr webinar will review the trial's recent evolution & will engage advocacy partners in discussion to paint a clearer picture of current and emerging patient needs in #NSCLC. Register at: friendsofcancerresearch.org/event/lung-m...
- Our @swog.org group chair's blog: Back from SF, I can say our newly consolidated group meeting schedule (cut from 4 days to 3) was a success! My chair’s update at plenary covered some unusual ground, such as recent federal directives that have had an impact on SWOG. www.swog.org/news-events/...
- Our #TranslationalMedicine Link of the Week, chosen by @swog.org's Lee Ellis, MD, & Jimmy Rae, PhD: ALK in Cancer: From Function to Therapeutic Targeting doi.org/10.1038/s415...
- Reposted by SWOG Cancer Research NetworkDeeply saddened that the ENTIRE TEAM at NCI PDQ Cancer Information has been eliminated. Our evidence-based summaries were updated throughout the year with the latest research and supported informed decision making between clinicians & patients with cancer across the US. 🇺🇸
- Register for a Lung-MAP public webinar: "Advocating, Accelerating, and Amplifying Lung Cancer Discovery," Wed., May 14, 1-2 pm ET. Hear Lung-MAP experts & a panel of #lungcancer advocates on trial updates, oppts for patient engagement, & more. friendsofcancerresearch.org/event/lung-m...
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- At @swog.org spring group mtg, Lung-MAP Site Coordinators Cmte discusses new S1800E non-match sub-study, just activated. For patients w advanced #NSCLC w/out genomic match to a biomarker-targeted sub-study. Details at swog.org/clinical-tri... & patient info at swog.org/S1800E #SWOGonc
- In @swog.org group mtg GU cmte session, Dr. Leslie Ballas presents on S2427 BRIGHT trial, activating this summer. Bladder preserv w chemoRT or IO-RT after good response to neoadjuvant chemo in patients w muscle invasive #bladdercancer. Do pts who respond to neoadjuv chemo need cystectomy? #SWOGonc
- .@drdonsdizon.bsky.social at @swog.org group meeting #AYA cmte session, presenting on challenges of and approaches to discussing sexual health and intimacy issues with adolescents and young adults with #cancer. #SWOGonc
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- These are truly amazing people in their commitment, abilities, expertise, & hard-won experience. @swog.org benefits enormously from the collaboration of our #advocates -- better trials, more meaningful outcomes, greater impact improving lives. Thank you to all in the SWOG #patientadvocate committee!
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- SWOG group chair Dr. Charles Blanke addresses the Site Operations session at the spring meeting on questions of steps SWOG has taken and expects to take in navigating the new cancer research landscape of 2025. Recordings of some sessions will be available to SWOG members www.swog.org/news-events/...
- At the digital engagement cmte session at the SWOG group mtg in SF, Dr. Heather Greenlee @fredhutch.bsky.social presents on cookforyourlife.org, a website on nutrition for patients with cancer that's also used to ask & answer: What supports are needed to promote healthy nutrition behaviors? #SWOGonc
- Day 1 of the @swog.org spring group meeting in SF! New CRAs spend the day in our Clin Trials Training Course, & our #NCORP research cmtes all meet today. Plus, 1 symposium on engaging older patients and another on engaging AYAs. Learn more: www.swog.org/news-events/... #SWOGonc
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- SWOG members are headed to San Francisco -- some IRL, others virtually -- to the spring group meeting. 3 days of education, trial design, research strategy, professional development, & colleagues! Details, agendas, and Zoom links at: www.swog.org/news-events/... See you in SF!
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- #ClinicalTrial S2312 tests a combination of chemo drugs for castrate-resistant #prostatecancer. Participants receive tumor testing to find out if their cancer is aggressive variant prostate cancer. swog.org/S2312. Or call 1-800-4-CANCER. #pcsm
- Our @swog.org group chair's blog: Next Week in San Francisco ... We’ve reduced the # of days at spring group meeting, but we haven't reduced the range of exciting opportunities for education, networking, & prof development. I’m really looking forward to San Francisco! www.swog.org/news-events/...
- Our #TranslationalMedicine Link of the Week, chosen by @swog.org's Lee Ellis, MD, & Jimmy Rae, PhD: Microbiota-Centered Interventions to Boost Immune Checkpoint Blockade Therapies doi.org/10.1084/jem....
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- The Lung-MAP Accrual Enhancement Committee is hosting the "Advocating, Accelerating, and Amplifying #LungCancer Discovery" webinar on May 14. Learn about #ClinicalTrial updates, Lung-MAP's advantages, and patient engagement opportunities. Register today: bit.ly/3EpG5Yx #NSCLC #lcsm
- Phase 3 @swog.org S2312 randomizes patients with metastatic castrate-resistant #ProstateCancer to cabazitaxel w or w/out carboplatin. All are screened for an aggressive variant signature (AVPC-MS), used to stratify. Co-PIs: Drs. Ana Aparicio & David VanderWeele swog.org/clinical-tri... #pcsm
- Our #TranslationalMedicine Link of the Week, chosen by @swog.org's Lee Ellis, MD, & Jimmy Rae, PhD: This week’s edition of TM Link of the Week is a full issue of the journal Cancer Cell, with several research articles, reviews, and commentaries. www.sciencedirect.com/journal/canc...
- Our @swog.org group chair's Front Line blog: Group Meeting Preview: Committee Session Riches Here are just some of the great keynote talks that will be presented within individual committee sessions in San Francisco next month. www.swog.org/news-events/...
- #ClinicalTrial S2414 asks: Do patients with early-stage #NSCLC with a pathologic complete response to neoadjuvant chemo-immunotherapy also need adjuvant immune checkpoint inhibitor therapy? S2414 compares adjuvant durvalumab to surveillance. #lcsm PI: Jeremy Cetnar, MD @ohsuknight.bsky.social
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- Patients with #lungcancer enrolling to Lung-MAP can now be matched to a targeted treatment trial based on prior genomic testing, without submitting new tumor or blood samples, making Lung-MAP 3.0 accessible to more patients at a wider range of clinical sites. #lcsm www.swog.org/news-events/...
- An amazing effort by all involved, and @swog.org is proud and grateful for this support for the Early Stage Investigator Training Course! Thank you @supportingswog.bsky.social !
- Our @swog.org group chair's blog: An ASCO Hill Day in Interesting Times I was in DC last week to advocate for consistent+ funding for NIH, NCI, and ARPA-H in FY2026 and for other policies important to cancer research & to patients with cancer. #ASCOAdvocacySummit www.swog.org/news-events/...
- Amazing support from Dr. Parminder Singh and his team helping @supportingswog.bsky.social support the @swog.org Early Stage Investigator Training Course and early career oncology researchers! Profoundly grateful to all involved! 🙏🙏🙏
- S2303 #PARAMUNE trial tests an anti-VEGFR2 + anti-PD1/L1 combo in patients w #gastric, #GEJ, or esophageal #adenocarcinoma whose dx progressed on (or who were intolerant to) 1st-line chemo + PD1/L1 inhibitor. swog.org/clinical-tri... Co-PI: Paul Oberstein, MD @nyulangone.bsky.social #gicsm #esocsm
- Online registration for @swog.org spring group meeting closes Friday, April 18. Events in SF will include info sessions on 3 new #NCORP trials and special symposia on geriatric oncology, engaging AYAs, and the role of AI in treating urologic tumors. Register now! www.swog.org/news-events/...
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- @swog.org leaders at @ascocancer.bsky.social #ASCOAdvocacySummit 2025 in DC: Drs. Paul Hesketh, Charles Blanke, Anne Chiang, Raymond Osarogiagbon, Rafeh Naqash. Goals: - Robust federal funding for #CancerResearch, NCI, & NIH - #FixPriorAuth - #DrugShortages solutions
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- Lung-MAP is a #clinicaltrial for non-small cell #lungcancer that tests patients’ cancer cells for gene changes. If your cancer has extra copies of the MET gene, Lung-MAP’s S1900J sub-study may be a treatment option for you. Visit SWOG.org/S1900J. Or call 1-800-4-CANCER. #lcsm
- "Among the most notable federally funded trials are those that revolutionized bladder cancer treatment, such as the SWOG 8507 trial, ..." The Importance of Federal Funding in Cancer Research: A Call to Action www.urologytimes.com/view/the-imp... via @urologytimes.bsky.social
- Our #TranslationalMedicine link of the week, chosen by @swog.org's Lee Ellis, MD, & Jimmy Rae, PhD: Artificial Intelligence-Based Biomarkers for Treatment Decisions in Oncology doi.org/10.1016/j.tr...
- Our @swog.org group chair's blog: TM Link of the Week: When Things Just Click Our translational medicine leadership has brought many symposia, workshops, retreats, & plenaries to members. For 12 yrs, they've also offered a curated TM article each week to busy clinicians www.swog.org/news-events/...
- Congratulations to @swog.org patient advocate Desiree A.H. Walker on being recognized with the 2025 Ellen Stovall Award for Innovation in Patient-Centered Care by the National Coalition for Cancer Survivorship! @ammercurio.bsky.social @barbarasegarra.bsky.social canceradvocacy.org/nccs-to-reco...
- Next-generation sequencing (NGS) of tumors has become a standard part of the treatment process for most patients with #NSCLC. Lung-MAP 3.0 can use results of a patient’s prior NGS testing to assign the patient to a targeted Lung-MAP sub-study. @cancerresearch.bsky.social lung-map.org
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- #myeloMATCH sub-study MM1OA-S03 is open! Patients registered to MYELOMATCH screening protocol who are 60+ or unfit for chemo and have AML w an IDH2 gene mutation may be assigned. Randomized to venetoclax + ASTX727 w/wo enasidenib. swog.org/clinical-trials/MM1OA-S03 @beatalleukemia.bsky.social
- #myeloMATCH substudies treat patients with #AML or #MDS sequentially from diagnosis thru all treatment stages. After each treatment, patients are rescreened for assignment to a substudy in another tier. #NCI @eaonc.bsky.social @swog.org swog.org/myeloMATCH-overview
- Congratulations, @drdonsdizon.bsky.social, on your next adventure!!
- Like I said, change is a good thing. Sad to leave Brown University Health but super excited to join such a venerable institution as @tuftsmedschool.bsky.social
- Reposted by SWOG Cancer Research NetworkEvery treatment used in medical practice, from aspirin to the most complicated chemotherapy regimens, was research at some point. Without medical research, there would be no medical treatments. Medical research saves lives.
- Now enrolling: @swog.org S2213 phase 3 study in patients newly diagnosed with AL #amyloidosis. Compares #stemcelltransplant to consolidation with Dara-VCD. Also compares patient #HRQoL and MRD negativity. PI: Patrick Hagen, MD, MPH @loyolachicago.bsky.social SWOG.org/clinical-trialal-trials/S2213
- Our @swog.org group chair's blog: * 25 Years of Our Early-Stage Investigator Training Course Our flagship training workshop for early-career researchers has had enormous impact over its first quarter century. @supportingswog.bsky.social www.swog.org/news-events/...
- Our #TranslationalMedicine link of the week, chosen by @swog.org's Lee Ellis, MD, & Jimmy Rae, PhD: A SITC Vision: Adapting Clinical Trials to Accelerate Drug Development in Cancer Immunotherapy doi.org/10.1136/jitc...
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- S2212 SCARLET is a randomized @swog.org ph 3 trial of treatment de-escalation in early-stage #triplenegative #breastcancer, comparing neoadjuvant immunotherapy + chemo w/wo anthracyclines. #TNBC SWOG.org/clinical-trials/S2212 PI: Priyanka Sharma, MD @ibcresearch1.bsky.social @raalbany.bsky.social
- Our group chair's blog: The S2212 De-Escalation Trial: Only in Public-Powered Research S2212 in triple-negative #breastcancer collects patient-reported outcomes to tell us whether shorter, anthracycline-free treatment is efficacious & easier for patients #bcsm www.swog.org/news-events/...
- Our #TranslationalMedicine link of the week (#2 of 2), chosen by @swog.org's Lee Ellis, MD & Jimmy Rae, PhD: Integrating Artificial Intelligence in Drug Discovery and Early Drug Development: A Transformative Approach doi.org/10.1186/s403...
- Our #TranslationalMedicine link of the week (#1 of 2), chosen by @swog.org's Lee Ellis, MD & Jimmy Rae, PhD: Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing Next-Generation #PrecisionOncology to Patients doi.org/10.18632/onc...
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- For sites enrolling to the S1931 PROBE trial in advanced #KidneyCancer #RenalCellCarcinoma: CIRB-approved patient education video at swog.org/patients/S1931
- Reposted by SWOG Cancer Research Network[Not loaded yet]
- Our #TranslationalMedicine link of the week, chosen by @swog.org's Lee Ellis, MD, & Jimmy Rae, PhD: Tumour-Agnostic Kinase Inhibitors doi.org/10.1038/s415...
- From our @swog.org group chair's blog: Meet the Advocate: Anne Marie Mercurio The co-chair of SWOG’s patient advocate committee since October 2023 has been a social media pioneer in advocating for those with cancer. @ammercurio.bsky.social www.swog.org/news-events/...
- Learn about some of @swog.org's most significant recent research results at our one-hour Best of SWOG webinar Wed., Mar 26, 2pm ET/ 11am PT Please register at ohsu.webex.com/weblink/regi...
